NCT06809673View on ClinicalTrials.gov

PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial

Enrolling by invitationOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions

Head and Neck Cancer

Interventions

OTHER

blood sampling

"blood sampling at baseline, 1,3,6 months after surgery and eventually when recurrence is detected.~If adjuvant treatment is planned, blood sampling at baseline, 1 month after surgery, 1,3,6 months after the last fraction of RT and eventually when recurrence is detected."

Trial Locations (1)

16132

IRCCS Policlinico San Martino, Genoa

All Listed Sponsors

lead

Ospedale Policlinico San Martino

OTHER